Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of the Optimal Treatment Strategy for Patients With Gastrointestinal Bleeding Due to Gastrointestinal Vascular Malformation: a Randomized, Double Blind, Placebo Controlled Study

NCT02301949 is registered in ClinicalTrials.gov with Zhizheng Ge as lead sponsor.

NCT NCT02301949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02301949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of the Optimal Treatment Strategy for Patients With Gastrointestinal Bleeding Due to Gastrointestinal Vascular Malformation: a Randomized, Double Blind, Placebo Controlled Study
Lead sponsor
Zhizheng Ge
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2015
Completion date
December 31, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal bleeding of unknown origin, gastrointestinal vascular malformation, thalidomide efficiency